CT631ZZ
Nonimaging Nuclear Medicine Assay Kidneys, Ureters and Bladder to None with None, Technetium 99m (Tc-99m) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | T Urinary System |
| Operation | 6 Nonimaging Nuclear Medicine Assay |
| Body Part | 3 Kidneys, Ureters and Bladder |
| Approach | 1 Technetium 99m (Tc-99m) |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for the study of body fluids and blood elements, by the detection of radioactive emissions
Procedure Overview
A nonimaging nuclear medicine assay of the urinary system measures radioactivity in blood or urine samples after a small dose of a radioactive tracer is given, rather than producing a picture. The most common example is a glomerular filtration rate study, where a tracer such as technetium-99m DTPA or iothalamate clears from the bloodstream at a rate that reflects how well the kidneys are filtering waste.
Physicians order this type of study to get a precise, numeric measure of kidney function, which is valuable before starting nephrotoxic chemotherapy, evaluating a potential kidney transplant donor, or monitoring progressive kidney disease. Because the result is a calculated number rather than an image, it can detect subtle declines in function that would not yet show up as a visible defect on a scan.
The test typically involves an injection followed by timed blood draws or urine collections over several hours, which a laboratory then analyzes for radioactive counts to derive the filtration rate.
Anatomy & Axis Detail
Kidneys, Ureters and Bladder
A nonimaging nuclear medicine assay of the kidneys, ureters, and bladder measures a physiologic parameter, most commonly glomerular filtration rate or split renal function, using radiotracer counts sampled from blood or urine rather than producing a picture of the anatomy. This distinction matters clinically because quantifying function, such as comparing clearance contributed by each kidney, often answers the referring question more directly than an image would, particularly before nephrectomy or in monitoring a transplanted kidney. Because no image is generated, the study is documented through counting data and calculated values rather than a set of views, and the report should make clear which components of the tract contributed to the measured activity. This code applies specifically when the analytic target spans the kidneys, ureters, and bladder as a functional unit.
Radionuclide: Technetium 99m (Tc-99m)
Technetium 99m (Tc-99m) is the most widely used radionuclide in Nuclear Medicine, valued for its short half-life and favorable gamma energy for imaging bone, cardiac, renal, and other organ systems. In this axis position it records that a technetium-based radiopharmaceutical was the tracer administered for the study, distinguishing it from the many other specific isotopes, such as thallium or iodine compounds, used for more specialized indications.
Coding & Documentation
Documentation supporting this code should show that the radioactive material was introduced specifically to analyze a body fluid sample, such as blood or urine, for its radioactivity level, with no imaging device or camera acquisition involved. Look for laboratory or nuclear medicine reports referencing counts per minute, clearance calculations, or a calculated GFR rather than a scan reading. A common assignment error is applying this root operation to a renal scan that also happens to report a functional percentage, when in fact that percentage was derived from image-based counts and belongs under an imaging root operation instead. Coders should also verify that the sample collection and tracer administration are documented together, since a GFR calculated from serum creatinine alone, without a radioactive tracer, does not qualify for this family at all.
Commonly Confused With
The key distinction from Tomographic or Planar Nuclear Medicine Imaging of the urinary system is that no image is ever produced here; the tracer is tracked only through laboratory measurement of samples, not a camera. It is also sometimes confused with standard, non-nuclear renal function testing, such as a creatinine clearance test, which uses no radioactive material and therefore falls outside the Nuclear Medicine section altogether.